• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

DWS Health and Wellness Fund

+ Add to Watchlist

SUHAX:US

37.76 USD 0.81 2.10%

As of 19:59:59 ET on 07/31/2014.

Snapshot for DWS Health and Wellness Fund (SUHAX)

Year To Date: +12.78% 3-Month: +8.28% 3-Year: +23.88% 52-Week Range: 29.59 - 38.75
1-Month: +1.88% 1-Year: +27.47% 5-Year: +20.41% Beta vs MXWO: 0.89

Mutual Fund Chart for SUHAX

No chart data available.
  • SUHAX:US 37.76
  • 1M
  • 1Y
Interactive SUHAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SUHAX

DWS Health and Wellness Fund is an open-end fund incorporated in the USA. The objective is to seek long-term growth of capital. The Fund invests at least 80% of its assets in the health care sector. This includes pharmaceuticals, biotechnology, medical products and supplies, and health care services. The fund will invest mainly in US companies, but it may invest in foreign companies.

Inception Date: 12-29-2000 Telephone: 1-800-730-1313
Managers: THOMAS E BUCHER / PETER BARSA
Web Site: www.dws-investments.com

Fundamentals for SUHAX

NAV (on 2014-07-31) 37.76
Assets (M) (on 2014-07-30) 321.59
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 50.00

Dividends for SUHAX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2013-12-13) 0.53
Dividend Yield (ttm) 6.66

Fees & Expenses for SUHAX

Front Load 5.75
Back Load 0.00
Current Mgmt Fee 0.77
Redemption Fee 2.00
12b1 Fee 0.24
Expense Ratio 1.37

Top Fund Holdings for SUHAX

Filing Date: 05/30/2014
Name Position Value % of Total
Gilead Sciences Inc 149,173 12,114,339 3.966%
Merck & Co Inc 188,701 10,918,240 3.575%
Johnson & Johnson 98,733 10,017,450 3.280%
Biogen Idec Inc 30,397 9,707,890 3.178%
Bristol-Myers Squibb Co 181,365 9,021,095 2.954%
Actavis plc 40,466 8,560,178 2.803%
Pfizer Inc 274,656 8,138,057 2.664%
Investors Cash Trust - Treasur 7,757,040 7,757,040 2.540%
AbbVie Inc 139,414 7,574,363 2.480%
Amgen Inc 63,067 7,315,141 2.395%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil